Respiratory Medicine

  1. Interstitial lung damage following COVID-19 hospitalisation: an interim analysis of the UKILD Post-COVID study

    1. I Stewart
    2. J Jacob
    3. PM George
    4. PL Molyneaux
    5. JC Porter
    6. RJ Allen
    7. JK Baillie
    8. SL Barratt
    9. P Beirne
    10. SM Bianchi
    11. JF Blaikley
    12. J Chalmers
    13. RC Chambers
    14. N Chadhuri
    15. C Coleman
    16. G Collier
    17. EK Denneny
    18. A Docherty
    19. O Elneima
    20. RA Evans
    21. L Fabbri
    22. MA Gibbons
    23. FV Gleeson
    24. B Gooptu
    25. NJ Greening
    26. B Guillen Guio
    27. IP Hall
    28. NA Hanley
    29. V Harris
    30. EM Harrison
    31. M Heightman
    32. TE Hillman
    33. A Horsley
    34. L Houchen-Wolloff
    35. I Jarrold
    36. SR Johnson
    37. MG Jones
    38. F Khan
    39. R Lawson
    40. OC Leavy
    41. N Lone
    42. M Marks
    43. H McAuley
    44. P Mehta
    45. E Omer
    46. D Parekh
    47. K Piper Hanley
    48. M Platé
    49. J Pearl
    50. K Poinasamy
    51. JK Quint
    52. B Raman
    53. M Richardson
    54. P Rivera-Ortega
    55. LC Saunders
    56. R Saunders
    57. MG Semple
    58. M Sereno
    59. A Shikotra
    60. AJ Simpson
    61. A Singapuri
    62. DJF Smith
    63. M Spears
    64. LG Spencer
    65. S Stanel
    66. D Thickett
    67. AAR Thompson
    68. M Thorpe
    69. R Thwaites
    70. SLF Walsh
    71. S Walker
    72. ND Weatherley
    73. M Weeks
    74. JM Wild
    75. DG Wootton
    76. CE Brightling
    77. LP Ho
    78. LV Wain
    79. RG Jenkins

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Polymorphism in IFNAR contributes to glucocorticoid response and outcome in ARDS and COVID-19

    1. Juho Jalkanen
    2. Sofia Khan
    3. Kati Elima
    4. Teppo Huttunen
    5. Ning Wang
    6. Maija Hollmén
    7. Laura L. Elo
    8. Sirpa Jalkanen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. 13 cis retinoic acid improved the outcomes of COVID-19 patients. A randomized clinical trial

    1. Mahmoud Elkazzaz
    2. Yousry Esam-Eldin Abo-Amer
    3. Amr Ahmed
    4. Tamer Haydara

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Patients at risk of pulmonary fibrosis Post Covid-19: Epidemiology, pulmonary sequelaes and humoral response

    1. Miriam Hernández Porto
    2. Teresa Delgado
    3. Armando Aguirre-Jaime
    4. María Jose Ramos
    5. Silvia Campos
    6. Orlando Acosta
    7. Ana Belén Llanos
    8. María Lecuona

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Proteome reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients

    1. Alina Bauer
    2. Elisabeth Pachl
    3. Johannes C. Hellmuth
    4. Nikolaus Kneidinger
    5. Marion Frankenberger
    6. Hans C. Stubbe
    7. Bernhard Ryffel
    8. Agnese Petrera
    9. Stefanie M. Hauck
    10. Jürgen Behr
    11. Rainer Kaiser
    12. Clemens Scherer
    13. Li Deng
    14. Daniel Teupser
    15. Narges Ahmidi
    16. Maximilian Muenchhoff
    17. Benjamin Schubert
    18. Anne Hilgendorff

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Efficacy of Lactococcus lactis strain plasma (LC-Plasma) in easing symptoms in patients with mild COVID-19: protocol for an exploratory, multicentre, double-blinded, randomised controlled trial (PLATEAU study)

    1. Kazuko Yamamoto
    2. Naoki Hosogaya
    3. Tsuyoshi Inoue
    4. Kenta Jounai
    5. Ryohei Tsuji
    6. Daisuke Fujiwara
    7. Katsunori Yanagihara
    8. Koichi Izumikawa
    9. Hiroshi Mukae

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Summarizing Study Characteristics and Diagnostic Performance of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 Era

    1. David I Bernstein
    2. Asuncion Mejias
    3. Barbara Rath
    4. Christopher W Woods
    5. Jamie Phillips Deeter

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. DNA Aptamer Gold Nanoparticle Colorimetric Diagnostic Test Kit of Saliva Samples for SARS_Cov2 Virus Linked to Mobile Phone Application (Aptamex™)

    1. Siska Nurul Chotimah
    2. Yudhistira Eka Putra
    3. Jocelyn H. Ng
    4. Agustyas Tijptaningrum
    5. Nabilla Sonia Sahara
    6. Arfianti
    7. Ridha Amaliah
    8. Michael J. Edel
    9. Mayreli Ortiz Rodriguez
    10. Teresa Mairal Llerga
    11. Ciara K. O’Sullivan
    12. Steven Goh

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. A model-based approach to improve intranasal sprays for respiratory viral infections

    1. Saikat Basu
    2. Mohammad Mehedi Hasan Akash
    3. Yueying Lao
    4. Pallavi A Balivada
    5. Phoebe Ato
    6. Nogaye K Ka
    7. Austin Mituniewicz
    8. Zachary Silfen
    9. Julie Suman
    10. Arijit Chakravarty
    11. Diane Joseph-McCarthy

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Aerosol measurement identifies SARS-CoV 2 PCR positive adults compared with healthy controls

    1. Desireé Gutmann
    2. Gerhard Scheuch
    3. Timon Lehmkühler
    4. Laura-Sabine Herrlich
    5. Anton Landeis
    6. Martin Hutter
    7. Christoph Stephan
    8. Maria Vehreschild
    9. Yascha Khodamoradi
    10. Ann-Kathrin Gossmann
    11. Florian King
    12. Frederik Weis
    13. Maximilian Weiss
    14. Holger F. Rabenau
    15. Juergen Graf
    16. Helena Donath
    17. Ralf Schubert
    18. Stefan Zielen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 9 of 24 Next